Mood stabilisers plus risperidone or placebo in the treatment of acute mania: International, double-blind, randomised controlled trial

British Journal of Psychiatry

Volumn 182, Issue FEB., 2003, Pages 141-147

  Yatham, Lakshmi N ^a   Grossman, Fred ^a   Augustyns, Ilse ^a   Vieta, Eduard ^a   Ravindran, Arun ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; LITHIUM; LORAZEPAM; NEUROLEPTIC AGENT; PLACEBO; RISPERIDONE; VALPROATE SEMISODIUM;

ADULT; ARTICLE; ATAXIA; BIPOLAR DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DYSKINESIA; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; FEMALE; GAIT DISORDER; HEADACHE; HUMAN; HYPERKINESIA; HYPOKINESIA; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MANIA; MENTAL DISEASE; MOOD; MULTICENTER STUDY; MUSCLE HYPERTONIA; NAUSEA; PARKINSONISM; PHASE 3 CLINICAL TRIAL; PSYCHOPHARMACOTHERAPY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SYMPTOMATOLOGY; TETANY; TREATMENT OUTCOME; TREMOR;

ADULT; AGED; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; BASAL GANGLIA DISEASES; BIPOLAR DISORDER; BRIEF PSYCHIATRIC RATING SCALE; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LITHIUM COMPOUNDS; LORAZEPAM; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RISPERIDONE; TREATMENT OUTCOME; TREATMENT REFUSAL; VALPROIC ACID;

EID: 0037317783     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.182.2.141     Document Type: Article

References (18)

1. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV). Washington, DC: APA.
2. _ (2002) Practice guideline for the treatment of patients with bipolar disorder (revision). American Journal of Psychiatry, 159 (suppl.), 1-50.
3. Aubrey, A. M., Simon, A. E. & Bertsky, C. (2000) Possible induction of mania and hypomania by olanzapine or risperidone: a critical review of reported cases. Journal of Clinical Psychiatry, 61, 649-655.
4. Chouinard, G., Ross-Chouinard, A., Annable, L., et al (1980) Extrapyramidal Symptom Rating Scale (abstract). Canadian Journal of Neurological Science, 7, 233.
5. Freeman, M. P. & Stoll, A. L. (1998) Mood stabiliser combinations: a review of safety and efficacy. American Journal of Psychiatry, 155, 12-21.
6. Ghaemi, S. N. & Sachs, G. S. (1997) Long-term risperidone treatment in bipolar disorder: 6-month follow-up. International Clinical Psychopharmacology, 12, 333-338.
7. _, Baldassano, C. F., et al (1997) Acute treatment of bipolar disorder with adjunctive risperidone in outpatients. Canadian Journal of Psychiatry, 42, 196-199.
8. Guy, W. (ed.) (1976) ECDEU Assessment Manual for Psychopharmacology, Revised. DHEW Publication No. (ADM) 76. Rockville, MD: DHEW.
9. Hamilton, M. (1967) Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology, 6, 278-296.
10. Overall, J. E. & Gorham, D. R. (1962) The Brief Psychiatric Rating Scale. Psychological Reports, 10, 799-812.
11. Sachs, G. S., Printz, D. J., Kahn, D. A., et al (2000) The Expert Consensus Guideline Series: Medication treatment of bipolar disorder. Postgraduate Medicine, April Special Report, 1-104.
12. Segal, J., Berk, M. & Brook, S. (1998) Risperidone compared with both lithium and haloperidol in mania: double-blind randomized controlled trial. Clinical Neuropharmacalogy, 21, 176-180.
13. Tohen, M., Jacobs, T. G., Grundy, S. L., et al (2000) Efficacy of olanzapine in acute bipolar mania: a double blind, placebo-controlled study. The olanzapine HGGW Study Group. Archives of General Psychiatry, 57, 841-849.
14. _, Chengappa, K. N., Suppes, T., et al (2002) Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Archives of General Psychiatry, 59, 62-69.
15. van Elteren, P. H. (1960) On the combination of independent two-sample tests of Wilcoxon. Bulletin of the International Statistical Institute, 37, 351-361.
16. Vieta, E., Corbella, B., Reinares, M., et al (2001) Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorder: results from a six-month, multicenter, open study. Journal of Clinical Psychiatry, 62, 818-825.
17. White, S. J. & Freedman, L. S. (1978) Allocation of patients to treatment groups in a controlled clinical study. British Journal of Cancer, 37, 849-857.
18. Young, R. C., Biggs, J. T., Ziegler, V. E., et al (1978) A rating scale for mania: reliability, validity and sensitivity. British Journal of Psychiatry, 133, 429-435.